BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20393189)

  • 1. Exploring new routes for neuroprotective drug development in traumatic brain injury.
    Janowitz T; Menon DK
    Sci Transl Med; 2010 Apr; 2(27):27rv1. PubMed ID: 20393189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.
    Loane DJ; Faden AI
    Trends Pharmacol Sci; 2010 Dec; 31(12):596-604. PubMed ID: 21035878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
    Marklund N; Hillered L
    Br J Pharmacol; 2011 Oct; 164(4):1207-29. PubMed ID: 21175576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach.
    Indraswari F; Wang H; Lei B; James ML; Kernagis D; Warner DS; Dawson HN; Laskowitz DT
    J Neurotrauma; 2012 May; 29(7):1388-400. PubMed ID: 22233347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection for traumatic brain injury.
    Loane DJ; Stoica BA; Faden AI
    Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational agents for treatment of traumatic brain injury.
    Xiong Y; Zhang Y; Mahmood A; Chopp M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of traumatic brain injury.
    Xiong Y; Mahmood A; Chopp M
    Nat Rev Neurosci; 2013 Feb; 14(2):128-42. PubMed ID: 23329160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
    Lerouet D; Marchand-Leroux C; Besson VC
    Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective strategies for traumatic brain injury: improving clinical translation.
    Kabadi SV; Faden AI
    Int J Mol Sci; 2014 Jan; 15(1):1216-36. PubMed ID: 24445258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential.
    Kövesdi E; Szabó-Meleg E; Abrahám IM
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics: in pursuit of effective traumatic brain injury therapeutics.
    Lizhnyak PN; Ottens AK
    Expert Rev Proteomics; 2015 Feb; 12(1):75-82. PubMed ID: 25603864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury.
    Hiskens MI
    J Pharmacol Exp Ther; 2022 Aug; 382(2):149-166. PubMed ID: 35644464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection and traumatic brain injury: the search continues.
    Faden AI
    Arch Neurol; 2001 Oct; 58(10):1553-5. PubMed ID: 11594912
    [No Abstract]   [Full Text] [Related]  

  • 15. Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality.
    Ishida K; Berger M; Nadler J; Warner DS
    Curr Pharm Des; 2014; 20(36):5751-65. PubMed ID: 24502575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
    Kumar A; Loane DJ
    Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury.
    Zhang Z; Larner SF; Kobeissy F; Hayes RL; Wang KK
    Methods Mol Biol; 2010; 662():317-29. PubMed ID: 20824479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study.
    Margulies SS; Kilbaugh T; Sullivan S; Smith C; Propert K; Byro M; Saliga K; Costine BA; Duhaime AC
    Brain Pathol; 2015 May; 25(3):289-303. PubMed ID: 25904045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of magnesium in traumatic brain injury.
    Sen AP; Gulati A
    Neurotherapeutics; 2010 Jan; 7(1):91-9. PubMed ID: 20129501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy.
    Kochanek PM; Bramlett H; Dietrich WD; Dixon CE; Hayes RL; Povlishock J; Tortella FC; Wang KK
    J Trauma; 2011 Jul; 71(1 Suppl):S15-24. PubMed ID: 21795873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.